Verve Therapeutics
Anthony Philippakis is a venture capitalist and data scientist. He was trained as a cardiologist at Brigham and Women’s Hospital, and he is currently a venture partner focusing on machine learning, distributed computing, and genomics at GV (formerly known as Google Ventures). He is also the chief data officer at the Broad Institute. Dr. Philippakis received his M.D. from Harvard Medical School and completed a Ph.D. in biophysics at Harvard. As an undergraduate, he studied mathematics at Yale University and later completed the Part III (equivalent to M.Phil) in mathematics at Cambridge University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Verve Therapeutics
59 followers
Verve Therapeutics is a biotechnology company focused on discovering and developing therapies that safely edit the genomes of adults to confer lifelong protection against coronary artery disease, the most common type of heart disease and the leading cause of death worldwide.